Hypocretin/orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1

ACS Chemical Neuroscience

Volumn 6, Issue 1, 2015, Pages 138-146

  Prince, Courtney D ^a   Rau, Andrew R ^b   Yorgason, Jordan T ^c   España, Rodrigo A ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Addiction; drug abuse; fast scan cyclic voltammetry; motivation; reward

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ALMOREXANT; COCAINE; DOPAMINE; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; BENZOXAZOLE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; HCRTR1 PROTEIN, RAT; NEUROPEPTIDE; OREXIN RECEPTOR; OREXIN RECEPTOR ANTAGONIST; SIGNAL PEPTIDE; UREA;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; DRUG SELF ADMINISTRATION; ELECTROCHEMICAL ANALYSIS; METABOLISM; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BENZOXAZOLES; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMICAL TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; OREXIN RECEPTOR ANTAGONISTS; OREXIN RECEPTORS; OREXINS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SIGNAL TRANSDUCTION; UREA;

EID: 84921448725     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500246j     Document Type: Article

References (64)

1. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richarson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., McNulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., and Yanagisawa, M. (1998) Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 92, 1
2. de Lecea, L. and Sutcliffe, J. G. (2005) The hypocretins and sleep FEBS J. 272, 5675-5688
3. Peyron, C., Tighe, D. K., van Den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., and Kilduff, T. S. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems J. Neurosci. 18, 9996-10015
4. Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., and Elmquist, J. K. (2001) Differential expression of orexin receptors 1 and 2 in the rat brain J. Comp. Neurol. 435, 6-25
5. Fadel, J. and Deutch, A. Y. (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area Neuroscience 111, 379-387
6. Martin, G., Fabre, V., Siggins, G. R., and de Lecea, L. (2002) Interaction of the hypocretins with neurotransmitters in the nucleus accumbens Regul. Pept. 104, 111-117
7. Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., and Brown, R. E. (2003) Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins J. Neurosci. 23, 7-11
8. Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., and Bonci, A. (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine Neuron 49, 589-601
9. España, R. A., Melchior, J. R., Roberts, D. C. S., and Jones, S. R. (2011) Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration Psychopharmacology (Berlin, Ger.) 214, 415-426
10. Moorman, D. E. and Aston-Jones, G. (2010) Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences J. Neurosci. 30, 15585-15599
11. España, R. A., Oleson, E. B., Locke, J. L., Brookshire, B. R., Roberts, D. C. S., and Jones, S. R. (2010) The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system Eur. J. Neurosci. 31, 336-348
12. Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., and de Lecea, L. (2005) Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior Proc. Natl. Acad. Sci. U. S. A. 102, 19168-19173
13. Harris, G. C., Wimmer, M., and Aston-Jones, G. (2005) A role for lateral hypothalamic orexin neurons in reward seeking Nature 437, 556-559
14. Aston-Jones, G., Smith, R. J., Moorman, D. E., and Richardson, K. A. (2009) Role of lateral hypothalamic orexin neurons in reward processing and addiction Neuropharmacology 56 (Suppl 1) 112-121
15. Smith, R. J., See, R. E., and Aston-Jones, G. (2009) Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking Eur. J. Neurosci. 30, 493-503
16. Smith, R. J., Tahsili-Fahadan, P., and Aston-Jones, G. (2010) Orexin/hypocretin is necessary for context-driven cocaine-seeking Neuropharmacology 58, 179-184
17. Mahler, S. V., Smith, R. J., and Aston-Jones, G. (2013) Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats Psychopharmacology (Berlin, Ger.) 226, 687-698
18. Borgland, S. L., Chang, S. J., Bowers, M. S., Thompson, J. L., Vittoz, N., Floresco, S. B., Chou, J., Chen, B. T., and Bonci, A. (2009) Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers J. Neurosci. 29, 11215-11225
19. Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J. T., Eisch, A. J., Yanagisawa, M., Nestler, E. J., and DiLeone, R. J. (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal J. Neurosci. 23, 3106-3111
20. Narita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., and Suzuki, T. (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine J. Neurosci. 26, 398-405
21. Hollander, J. A., Pham, D., Fowler, C. D., and Kenny, P. J. (2012) Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: Pharmacological and behavioral genetics evidence Front Behav. Neurosci. 6, 47
22. Muschamp, J. W., Hollander, J. A., Thompson, J. L., Voren, G., Hassinger, L. C., Onvani, S., Kamenecka, T. M., Borgland, S. L., Kenny, P. J., and Carlezon, W. A., Jr. (2014) Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area Proc. Natl. Acad. Sci. U. S. A. 111, E1648-E1655
23. Willie, J. T., Chemelli, R. M., Sinton, C. M., and Yanagisawa, M. (2001) To eat or to sleep? Orexin in the regulation of feeding and wakefulness Annu. Rev. Neurosci. 24, 429-458
24. Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., van, G. J., de Haas, S. L., Hess, P., Qiu, C., Buchmann, S., Scherz, M., Weller, T., Fischli, W., Clozel, M., and Jenck, F. (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans Nat. Med. 13, 150-155
25. Dugovic, C., Shelton, J. E., Aluisio, L. E., Fraser, I. C., Jiang, X., Sutton, S. W., Bonaventure, P., Yun, S., Li, X., Lord, B., Dvorak, C. A., Carruthers, N. I., and Lovenberg, T. W. (2009) Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat J. Pharmacol. Exp. Ther. 330, 142-151
26. Morairty, S. R., Revel, F. G., Malherbe, P., Moreau, J. L., Valladao, D., Wettstein, J. G., Kilduff, T. S., and Borroni, E. (2012) Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone PLoS One 7, e39131
27. Brown, R. M., Khoo, S. Y., and Lawrence, A. J. (2013) Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats Int. J. Neuropsychopharmacol. 16, 2067-2079
28. Anderson, R. I., Becker, H. C., Adams, B. L., Jesudason, C. D., and Rorick-Kehn, L. M. (2014) Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models Front. Neurosci. 8, 33
29. España, R. A., Roberts, D. C. S., and Jones, S. R. (2008) Short-acting cocaine and long-acting GBR-12909 both elicit rapid dopamine uptake inhibition following intravenous delivery Neuroscience 155, 250-257
30. Yorgason, J. T., Jones, S. R., and España, R. A. (2011) Low and high affinity dopamine transporter inhibitors block dopamine uptake within 5 sec of intravenous injection Neuroscience 182, 125-132
31. Lawrence, A. J., Cowen, M. S., Yang, H. J., Chen, F., and Oldfield, B. (2006) The orexin system regulates alcohol-seeking in rats Br. J. Pharmacol. 148, 752-759
32. Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., and Kenny, P. J. (2008) Insular hypocretin transmission regulates nicotine reward Proc. Natl. Acad. Sci. U. S. A. 105, 19480-19485
33. LeSage, M. G., Perry, J. L., Kotz, C. M., Shelley, D., and Corrigall, W. A. (2010) Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA Psychopharmacology (Berlin, Ger.) 209, 203-212
34. Korotkova, T. M., Brown, R. E., Sergeeva, O. A., Ponomarenko, A. A., and Haas, H. L. (2006) Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat Eur. J. Neurosci. 23, 2677-2685
35. Borgland, S. L., Storm, E., and Bonci, A. (2008) Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons Eur. J. Neurosci. 28, 1545-1556
36. Wise, R. A., Wang, B., and You, Z. B. (2008) Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release PLoS One 3, e2846
37. Aragona, B. J., Cleaveland, N. A., Stuber, G. D., Day, J. J., Carelli, R. M., and Wightman, R. M. (2008) Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events J. Neurosci. 28, 8821-8831
38. Venton, B. J., Seipel, A. T., Phillips, P. E., Wetsel, W. C., Gitler, D., Greengard, P., Augustine, G. J., and Wightman, R. M. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool J. Neurosci. 26, 3206-3209
39. Li, L. B., Chen, N., Ramamoorthy, S., Chi, L., Cui, X. N., Wang, L. C., and Reith, M. E. (2004) The role of N-glycosylation in function and surface trafficking of the human dopamine transporter J. Biol. Chem. 279, 21012-21020
40. Johnson, L. A., Furman, C. A., Zhang, M., Guptaroy, B., and Gnegy, M. E. (2005) Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation Neuropharmacology 49, 750-758
41. Mortensen, O. V., Larsen, M. B., Prasad, B. M., and Amara, S. G. (2008) Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking Mol. Biol. Cell 19, 2818-2829
42. Furman, C. A., Chen, R., Guptaroy, B., Zhang, M., Holz, R. W., and Gnegy, M. (2009) Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: Live-cell imaging using total internal reflection fluorescence microscopy J. Neurosci. 29, 3328-3336
43. Meiergerd, S. M., Patterson, T. A., and Schenk, J. O. (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: Kinetic evidence from studies in vitro and in vivo J. Neurochem. 61, 764-767
44. Cass, W. A. and Gerhardt, G. A. (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake Neurosci. Lett. 176, 259-263
45. Wu, Q., Reith, M. E., Walker, Q. D., Kuhn, C. M., Carroll, F. I., and Garris, P. A. (2002) Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: An in vivo voltammetric study J. Neurosci. 22, 6272-6281
46. Lee, F. J., Pei, L., Moszczynska, A., Vukusic, B., Fletcher, P. J., and Liu, F. (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor EMBO J. 26, 2127-2136
47. Choi, D. L., Davis, J. F., Magrisso, I. J., Fitzgerald, M. E., Lipton, J. W., and Benoit, S. C. (2012) Orexin signaling in the paraventricular thalamic nucleus modulates mesolimbic dopamine and hedonic feeding in the rat Neuroscience 210, 243-248
48. Barson, J. R., Ho, H. T., and Leibowitz, S. F. (2014) Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: role of orexin receptor 2 Addict. Biol. 10.1111/adb.12139
49. Mukai, K., Kim, J., Nakajima, K., Oomura, Y., Wayner, M. J., and Sasaki, K. (2009) Electrophysiological effects of orexin/hypocretin on nucleus accumbens shell neurons in rats: An in vitro study Peptides 30, 1487-1496
50. Mori, K., Kim, J., and Sasaki, K. (2011) Electrophysiological effects of orexin-B and dopamine on rat nucleus accumbens shell neurons in vitro Peptides 32, 246-252
51. Patyal, R., Woo, E. Y., and Borgland, S. L. (2012) Local hypocretin-1 modulates terminal dopamine concentration in the nucleus accumbens shell Front. Behav. Neurosci. 6, 82
52. Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., Munton, R. P., Ashmeade, T. E., Shah, A. S., Hatcher, J. P., Hatcher, P. D., Jones, D. N., Smith, M. I., Piper, D. C., Hunter, A. J., Porter, R. A., and Upton, N. (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat Proc. Natl. Acad. Sci. U. S. A. 96, 10911-10916
53. Bourgin, P., Huitron-Resendiz, S., Spier, A. D., Fabre, V., Morte, B., Criado, J. R., Sutcliffe, J. G., Henriksen, S. J., and de Lecea, L. (2000) Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons J. Neurosci. 20, 7760-7765
54. Piper, D. C., Upton, N., Smith, M. I., and Hunter, A. J. (2000) The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats Eur. J. Neurosci. 12, 726-730
55. España, R. A., Baldo, B. A., Kelley, A. E., and Berridge, C. W. (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin): Basal forebrain sites of action Neuroscience 106, 699-715
56. España, R. A., Plahn, S., and Berridge, C. W. (2002) Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin Brain Res. 943, 224-236
57. Deng, B. S., Nakamura, A., Zhang, W., Yanagisawa, M., Fukuda, Y., and Kuwaki, T. (2007) Contribution of orexin in hypercapnic chemoreflex: evidence from genetic and pharmacological disruption and supplementation studies in mice J. Appl. Physiol. 103, 1772-1779
58. Calipari, E. S. and España, R. A. (2012) Hypocretin/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms Front. Behav. Neurosci. 6, 54
59. Richardson, N. R. and Roberts, D. C. S. (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J. Neurosci. Methods 66, 1-11
60. Kuczenski, R., Segal, D. S., and Aizenstein, M. L. (1991) Amphetamine, Cocaine, and Fencamfamine-Relationship Between Locomotor and Stereotypy Response Profiles and Caudate and Accumbens-Dopamine Dynamics J. Neurosci. 11, 2703-2712
61. Jones, S. R., Garris, P. A., Kilts, C. D., and Wightman, R. M. (1995) Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat J. Neurochem. 64, 2581-2589
62. Wu, Q., Reith, M. E., Wightman, R. M., Kawagoe, K. T., and Garris, P. A. (2001) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry J. Neurosci. Methods 112, 119-133
63. Yorgason, J. T., España, R. A., and Jones, S. R. (2011) Demon Voltammetry and Analysis software: Analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures J. Neurosci. Methods 202, 158-164
64. Hirose, M., Egashira, S., Goto, Y., Hashihayata, T., Ohtake, N., Iwaasa, H., Hata, M., Fukami, T., Kanatani, A., and Yamada, K. (2003) N-Acyl 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline: The first orexin-2 receptor selective non-peptidic antagonist Bioorg. Med. Chem. Lett. 13, 4497-4499